Impactful Innovations.
Thoughtful Solutions.
Moving Results.

Dr. Czura is a molecular biologist who has been studying vagus nerve stimulation for the past 20 years. He has made seminal discoveries in neural control of bleeding and inflammation. Results of his research have supported the development of two bioelectronic medicine startup companies, the first of which recently closed Series D with total funding in excess of $80m to commercialize a proprietary implantable vagus nerve stimulator to treat rheumatoid arthritis. The second company is currently enrolling subjects for a clinical trial of a proprietary non-invasive vagus nerve stimulator to treat postpartum hemorrhage.

Chris served as Vice President of Scientific Affairs at the Feinstein Institute for Medical Research (Northwell Health, Manhasset, NY), overseeing all aspects of laboratory operations, the annual budget, and construction and renovation projects. He coordinated strategic plan development with the President and the Board of Directors, and represented the research portfolio to senior leadership of Northwell Health.

Chris has authored or co-authored over 100 peer-reviewed papers, book chapters and meeting abstracts, and presented to audiences in science, military, industry, venture capital and philanthropy. He has been awarded one international patent and has a second patent pending, and has raised over $50 million in sponsored research agreements and laboratory construction grants.

Mr. Lambert served as Founding Director of Innovation at the Center for Bioelectronic Medicine at the Karolinska Institutet (home of the Nobel Prize). For eight years, he consulted to the Feinstein Institute for Medical Research, providing strategic planning and communications expertise as it introduced bioelectronic medicine to the world.

Among other accomplishments, Mark created and served as Founding CEO of the Sepsis Alliance, the leading philanthropy dedicated to patient advocacy and public awareness of sepsis. He was also Founding Executive Director of the Global Sepsis Alliance, which, within 18 months of inception, grew to 600,000 caregivers in 63 countries.

While serving annually as a judge of the Anderson School (UCLA) Business Plan Competition, Mark supported the launch of BigPicture Investors, LLC, a Los Angeles-based angel investing entity offering early-stage financing, management expertise and assistance with the formation of growth capital.

Dr. Ogilvie is Professor and Division Director of Veterinary Oncology, University of California-San Diego, Moores Cancer Center and Director of the Angel Care Cancer Center at California Veterinary Specialists. At each of the three Centers, Greg, supported by a dedicated team of colleagues and state-of the–art technologies cares for patients and their families, teaches interns, residents, veterinary students and develops novel, new compassionate cancer therapies for pets and people.

Greg has authored/coauthored four books, written over 200 scientific articles and chapters as well as over 120 scientific abstracts and posters. He has been awarded two international patents in animal health therapeutics, over 10 million dollars in research grants and endowments as a principal or co-investigator, and is the recipient of many prestigious awards.

Greg has lectured in scores of countries to many thousands of students, veterinarians, physicians and scientists about his love of the practice of veterinary medicine and oncology.

© 2019 Convergent Medical Technologies, Inc.